PATENT CLAIM ANALYSIS

Application Number: 15751140
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "133100"]

Abstract:
The present invention relates to 5-bromo-2,6-di-(1H-pyrazol-1-yl)pyrimidin-4-amine, its pharmaceutically acceptable salts and co-crystals thereof and to pharmaceutical compositions comprising said compounds for use in the treatment of cancer.

Claim (Index 15):
The method according to  claim 2  wherein the compound of Formula I is administered in combination with an immunotherapeutic agent which is an anti-PD-L1 antibody.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.06452
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14604415', '15595618', '14881888', '14610837', '15469096']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8125205085363776
- 35 USC 102 Novelty (BERT): 0.5918018933634842
- Combined Prediction Score: 0.7904486470190882
- Mean Citation Score: 513.3936580000002
- Max Citation Score: 538.55566
- Similarity Product: 439.9716785996342

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test